Adial Pharmaceuticals, Inc. ( ADIL) - Stock Earnings
ADIL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
ADIL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.0 million USD | — USD |
| 2026Q1 | -2.0 million USD | — USD |
| 2026Q2 | -52.0 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ADIL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.0 million USD | — USD |
| 2024 | -13.2 million USD | — USD |
| 2025 | -8.0 million USD | — USD |
| 2026 Est. | — | — |
ADIL
Price: $5.45
52 week price:
Earnings Per Share: -4.89 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 498900
Market Capitalization: 14.3 million